risperidone
TMH-91-02
Approved small_molecule completed
Quick answer
risperidone for Neuroleptic-Induced Tardive Dyskinesia is a Approved program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
- Indication
- Neuroleptic-Induced Tardive Dyskinesia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed